IP Library Granted Patent US 12,495,800
Granted Patent B2
US 12,495,800 · App. 17/817,719 · Granted Dec 16, 2025

Protective barrier compositions, and uses thereof

Inventors: Nicholas T. Monsul (Sarasota, FL); Eva A. Berkes (Sarasota, FL); Frederick T. Boehm (Sarasota, FL)
Assignee: QUORUM INNOVATIONS, INC.
A01N63/20A61K35/747C09D5/14C12R2001/225
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,495,800
App. No.
17/817,719
Granted
Dec 16, 2025
Kind
B2
Abstract

The subject invention provides compositions and methods of enhancing the barrier function of surfaces and/or objects using biochemical-producing microbes and/or byproducts synthesized by the microbes. Preferred embodiments of the invention provide compositions, and the methods of using the same, comprising a Lactobacillus sp., and/or bioactive extracts thereof, derived from human microbiota and capable of growing in biofilm phenotype.

Claims (22)

1 . A surface, having applied thereto, a composition comprising inactivated Lactobacillus spp. that had been grown as biofilm, wherein the composition enhances a barrier such that, when the composition is applied to the surface, the surface becomes less susceptible to microbial, viral and/or chemical contamination, wherein the bacterial strain is L. fermentum Qi6 having Accession No. PTA-122195, and wherein the surface is on an object selected from medical instruments, countertops, protective suits, tables, appliances, chairs, dishes, utensils, medical implants, bandages, personal hygiene products, clothing, eyewear, footwear, headwear, masks, vehicles, boats, ships, cars, trucks, tanks, airplanes and trains.

2 . The surface, according to claim 1 , wherein the surface is on an object selected from medical instruments, countertops, protective suits, tables, appliances, chairs, dishes, utensils, medical implants, bandages, personal hygiene products, clothing, eyewear, footwear, headwear and masks.

3 . The surface, according to claim 1 , wherein the surface is on an object selected from vehicles, boats, ships, cars, trucks, tanks, airplanes and trains.

4 . The surface, according to claim 2 , wherein the surface is on a medical instrument.

5 . The surface, according to claim 2 , wherein the surface is on a protective suit.

6 . The surface, according to claim 2 , wherein the surface is on a medical implant.

7 . The surface, according to claim 2 , wherein the surface is on a bandage.

8 . The surface, according to claim 2 , wherein the surface is on a personal hygiene product.

9 . The surface, according to claim 2 , wherein the surface is on a mask.

10 . A method for enhancing a barrier against chemical, viral and/or microbial contamination of a surface, wherein said method comprises applying to the surface a composition comprising inactivated Lactobacillus spp. that had been grown as a biofilm, wherein when the composition is applied to the surface, the surface becomes less susceptible to microbial, viral and/or chemical contamination, and wherein the bacterial strain is L. fermentum Qi6 having Accession No, PTA-122195.

11 . The method of claim 10 , wherein the surface is selected from skin, intestine, stomach, lung, eye, mouth, nose, ear, trachea, vagina, and esophagus of a subject.

12 . The method of claim 10 , wherein the surface is selected from medical instruments, countertops, protective suits, tables, appliances, chairs, dishes, utensils, medical implants, personal hygiene products, bandages, clothing, eyewear, footwear, headwear and masks.

13 . The method, according to claim 10 , wherein the surface is on an object selected from vehicles, boats, ships, cars, trucks, tanks, airplanes and trains.

14 . The method of claim 10 , wherein performance and/or longevity of the surface is enhanced by one or a combination of the following:

a) preventing or limiting direct contact with the surface by a living organism or a non-living substance;

b) preventing fouling of the surface by a living organism or a non-living substance;

c) sequestering a living organism or a non-living substance;

d) inactivating a living organism or a non-living substance;

e) increasing the durability, stability and/or longevity of the barrier; and

f) increasing the presence of commensal organisms.

15 . The method, according to claim 10 , wherein the surface becomes less susceptible to viral contamination.

16 . The method, according to claim 10 , wherein the surface becomes less susceptible to chemical contamination.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 30, 2025
From: QUORUM INNOVATIONS, LLC
To: QUORUM INNOVATIONS, INC.
Reel/Frame 072422/0357 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 9, 2022
From: MONSUL, NICHOLAS T.; BERKES, EVA A.; BOEHM, FREDERICK T.
To: QUORUM INNOVATIONS, LLC
Reel/Frame 060753/0202 →
Continuity (4)
Continuation 17103392 · Nov 24, 2020
Provisional Application 62940598 · Nov 26, 2019
Provisional Application 63016336 · Apr 28, 2020
Related Publication 20220378049A1 · Dec 1, 2022
References Cited (25)
US 9706778B2 · Berkes · 2017 [cited by examiner]
US 10004772B2 · Berkes · 2018 [cited by examiner]
US 10617726B2 · Berkes · 2020 [cited by examiner]
US 11457633B2 · Monsul · 2022 [cited by examiner]
US 11564957B2 · Berkes · 2023 [cited by examiner]
US 11826390B2 · Monsul · 2023 [cited by examiner]
US 20140037688A1 · Berkes et al. · 2014 [cited by applicant]
US 20170020139A1 · Berkes · 2017 [cited by examiner]
US 20220378049A1 · Monsul · 2022 [cited by examiner]
CN 108135947A · 2018 [cited by applicant]
JP 2018527322A · 2018 [cited by applicant]
WO 2017015275A1 · 2017 [cited by applicant]
WO 2020191620A1 · 2020 [cited by applicant]
WO 2021226318A1 · 2021 [cited by applicant]
WO 2021248111A9 · 2021 [cited by applicant]
Berkes et al. 2020 (Potentiated In vitro probiotic activities of Lactobacillus fermentum LfQi6 Biofilm Biomass Versus Planktonic Culture; Probiotics and Antimicrobial Proteins 12: 1097-1114) (Year: 2020). [cited by examiner]
Aoudia et al. 2015 (Biofilms of Lactobacillus plantarum and Lactobacillus fermentum: Effect on stress responses, antagonistic effects on pathogen growth and immunomodulatory properties; Food Microbiology 53: 51-59) (Yea… [cited by examiner]
Subhadra et al. 2015 (Draft Whole-Genome Sequence of Lactobacillus fermentum LfQi6, Derived from the Human Microbiome; Genome Announc 3(3):e00423-15. Doi:10.1128/genomeA.00423-15) (Year: 2015). [cited by examiner]
Greenspan et al. 1999 (Defining epitopes: It's not as easy as it seems; Nature Biotechnology, 17:936-937). (Year: 1999). [cited by examiner]
Aoudia, N., et al., “Biofilms of Lactobacillus plantarum and Lactobacillus fermentum: Effect on Stress Responses, Antagonistic Effects on Pathogen Growth and Immunomodulatory Properties.” Food Microbiology, 2016, 53: 51… [cited by applicant]
Greenspan, N., et al. “Defining epitopes: It's not as easy as it seems.” Nature Biotechnology, Oct. 1999, 17: 936-937. [cited by applicant]
Salas-Jara, M.J., et al., “Biofilm Forming Lactobacillus: New Challenges for the Development of Probiotics.” Microorganisms, 2016, 4(35): 1-14. [cited by applicant]
Subhadra, B., et al. “Draft Whole-Genome Sequence of Lactobacillus fermentum LfQi6, Derived from the Human Microbiome.” Genome Announcements, May/Jun. 2015, 3(3): e00423-15, pp. 1-2. [cited by applicant]
“Uncharacterized Protein LACFE_CDS0840 [Limosilactobacillus fermentum]”, NCBI GenBank accession No. AOR74302.1, 2017; <https://www.ncbi.nlm.nih.giv/protein/AOR74302.1?report=genbank&log$=protalign>, accessed Oct. 2, 202… [cited by applicant]
Berkes, E., et al. “Potentiated in vitro probiotic activities of Lactobacillus fermentum LfQi6 biofilm biomass versus planktonic culture.” Probiotics and antimicrobial proteins 12.3 (2020): pp. 1097-1114. [cited by applicant]